Discover

GLSI
Greenwich LifeSciences, Inc.
23.70
2 x 17.36
2 x 29.79
bid
ask
+
0.24
1.02%
2 @ 04:00 PM
23.03 -0.67 (2.81%)
Ytd12.80%
1y161.88%
22.86
day range
24.50
7.78
52 week range
34.10
Open23.51Prev Close23.46Low22.86High24.50Mkt Cap347.87M
Vol84.79KAvg Vol141.89KEPS-1.61P/EN/AForward P/E-14.83
Beta3.32Short Ratio21.41Inst. Own8.70%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1350-d Avg24.15200-d Avg19.641yr Est38.00

GLSI News

benzinga.com
Greenwich LifeSciences Q4 EPS $(0.58) Misses $(0.31) Estimate

Greenwich LifeSciences (NASDAQ:GLSI) reported quarterly losses of $(0.58) per share which missed the

benzinga.com
Greenwich LifeSciences Announces Published Abstract And Poster On Its Phase III FLAMINGO-01 Trial Fo

from the ASCO Annual Meeting 2026.The abstract is shown below and the poster being presented today c

benzinga.com
Greenwich LifeSciences Reports Progress in Late-Stage Breast Cancer Immunotherapy Trial

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutic

benzinga.com
Greenwich LifeSciences Receives Nasdaq Noncompliance Notice

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) ("Greenwich" or the "Company"), a clinica

Why Kyverna Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Kyverna Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket

Kyverna Therapeutics Inc (NASDAQ: KYTX) shares rose 25.8% in pre-market trading after positive trial

benzinga.com
Greenwich LifeSciences Reports 70%–80% Drop In Cancer Recurrence In Early Trial Data

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutic

benzinga.com
Greenwich LifeSciences Says Breast Cancer Therapy Could Double Patient Reach With New Patent Claims

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutic

benzinga.com
Greenwich LifeSciences Expands Breast Cancer Trial Across Major US Cancer Centers, Launches New Stud

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutic

benzinga.com
Greenwich Lifesciences' Preliminary Update Shows A Continued Reduction In The Recurrence Rate In The

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutic

benzinga.com
Greenwich LifeSciences Says FDA Approves The First Commercial Lot Of GP2 Vials For Use In FLAMINGO-0

STAFFORD, Texas, March 16, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the

benzinga.com
Greenwich LifeSciences Says Cash on Hand Can Cover 2026 as Breast Cancer Trial Advances

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutic

Sarepta Therapeutics, Lands' End, USA Rare Earth, CoreWeave And Other Big Stocks Moving Higher On Monday
benzinga.com
Sarepta Therapeutics, Lands' End, USA Rare Earth, CoreWeave And Other Big Stocks Moving Higher On Mo

Greenwich LifeSciences Stock Jumps After FDA Update
benzinga.com
Greenwich LifeSciences Stock Jumps After FDA Update

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) shares are trading higher after the company announced the

benzinga.com
Market-Moving News for January 22nd

BABA: 5% | Alibaba shares are trading higher on Bloomberg report of company moving toward IPO of its

12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session

benzinga.com
Greenwich LifeSciences Says FDA Clears First Commercial GP2 Lot for Phase III Breast Cancer Trial

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutic

Why OceanFirst Financial Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
benzinga.com
Why OceanFirst Financial Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tues

CapsoVision, ACM Research And Other Big Stocks Moving Higher On Tuesday
benzinga.com
CapsoVision, ACM Research And Other Big Stocks Moving Higher On Tuesday

benzinga.com
HC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Raises Price Target to $50

HC Wainwright & Co. analyst Yi Chen maintains Greenwich LifeSciences (NASDAQ:GLSI) with a Buy

What's Going On With Greenwich LifeSciences Stock Monday?
benzinga.com
What's Going On With Greenwich LifeSciences Stock Monday?

Greenwich LifeSciences shares are trading higher Monday after the company announced it extended its

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 42%? Here Are Other Stocks Moving In Monday's Mid-Day Session
benzinga.com
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 42%? Here Are Other Stocks Moving I

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

Why Aptevo Therapeutics Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Friday's Mid-Day Session
benzinga.com
Why Aptevo Therapeutics Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Frid

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

What's Going On With Greenwich LifeSciences Friday?
benzinga.com
What's Going On With Greenwich LifeSciences Friday?

Greenwich LifeSciences stock hits a new 52-week high! Discover how Greenwich LifeSciences is streaml

Why Is Greenwich LifeSciences Stock Surging After Data From Breast Cancer Vaccine?
benzinga.com
Why Is Greenwich LifeSciences Stock Surging After Data From Breast Cancer Vaccine?

Greenwich LifeSciences stock rose after Phase 3 data showed GLSI-100 cut breast cancer recurrence ra

12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

benzinga.com
Greenwich LifeSciences Reports Early FLAMINGO-01 Results Showing 80% Reduction In Cancer Recurrences

A preliminary analysis of recurrence rates by two methods to estimate the reduction in recurrence ra

benzinga.com
Greenwich Lifesciences Completed Enrollment In Open-Label HLA-A*02 Arm of FLAMINGO-01 Phase 3 Trial

In the double-blinded arms of the Phase III trial, approximately 500 HLA-A*02 patients are currently

benzinga.com
Greenwich Lifesciences Announces Phase 3 FLAMINGO-01 Trial Of GLSI-100, An Immunotherapy To Prevent

Flamingo-01 Progress to DateThe Company has achieved a major milestone by screening over 1,000 patie

benzinga.com
Greenwich LifeSciences Strengthens European Presence As Flamingo-01 Clinical Trial Adds Belgium To N

The Company's application to European regulators has been formally approved, adding Belgium as a

benzinga.com
Greenwich LifeSciences Takes Fight Against Breast Cancer Recurrence Global with Trial Expansion into

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutic

benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  On Monday, 369 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  During Monday's trading, 1214 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  On Wednesday, 807 companies reached new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 1043 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  Tuesday's session saw 211 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  During Thursday, 849 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  Wednesday's session saw 784 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week

benzinga.com
78 Biggest Movers From Friday

Gainers Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported c

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

    During Wednesday's morning trading, 400 companies set new 52-week lows.

benzinga.com
51 Biggest Movers From Friday

Gainers

benzinga.com
38 Stocks Moving In Friday's Mid-Day Session

Gainers

benzinga.com
84 Biggest Movers From Yesterday

Gainers

benzinga.com
60 Stocks Moving In Thursday's Mid-Day Session

Gainers Immutep Limited (NASDAQ: IMMP) shares jumped 198.6% to $6.42 after the company said its C

benzinga.com
70 Biggest Movers From Yesterday

Gainers Greenwich Lifesciences Inc (NASDAQ: GLSI) shares jumped 998.1% to close at $57.10 on Wedn